Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Family Practice|February 8, 2006
Chest pain in general practice: incidence, comorbidity and mortalityAna Ruigómez, Luis Alberto García Rodríguez, Mari-Ann Wallander, et al.
Clinical Cardiology|December 12, 2007
Risk of cerebrovascular accident after a first diagnosis of atrial fibrillationAna Ruigómez, Luis Alberto García Rodríguez, Saga Johansson, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2008
Self-reported use of pharmaceuticals among patients with irritable bowel syndrome in primary careAshild Faresjo, Ewa Grodzinsky, Saga Johansson, et al.
Health and Quality of Life Outcomes|March 29, 2006
Health-related quality of life of irritable bowel syndrome patients in different cultural settingsAshild Faresjö, Foteini Anastasiou, Christos Lionis, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2008
The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary careLuis Alberto García-Rodríguez, Elvira Luján Massó-González, Mari-Ann Wallander, et al.
International Journal of Cardiology|July 16, 2008
Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosisAna Ruigómez, Saga Johansson, Mari-Ann Wallander, et al.
Family Practice|August 31, 2007
Dyspepsia in general practice: incidence, risk factors, comorbidity and mortalityMari-Ann Wallander, Saga Johansson, Ana Ruigómez, et al.
Drug Safety|February 18, 2010
Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenariosSaga Johansson, Mari-Ann Wallander, Francisco J de Abajo, et al.
The American Journal of Gastroenterology|December 13, 2006
A population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome--women are more seriously affected than menAshild Faresjö, Ewa Grodzinsky, Saga Johansson, et al.
Pharmacoepidemiology and Drug Safety|September 25, 2014
The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement NetworkLucía Cea Soriano, Mari-Ann Wallander, Susan Andersson, et al.
Pageof 7